Updated on 2026/03/27

写真a

 
OHASHI Yuki
 
Organization
Graduate School of Medicine Assistant Professor
Graduate School
Graduate School of Medicine
Undergraduate School
School of Health Sciences
Title
Assistant Professor
External link

Degree 1

  1. 博士(薬学) ( 2023.3   東京薬科大学 ) 

Research Interests 6

  1. Uric acid

  2. トランスポーター

  3. 疫学

  4. 高尿酸血症

  5. 腎疫学

  6. 低尿酸血症

Research Areas 2

  1. Life Science / Nephrology

  2. Life Science / Hygiene and public health (laboratory)  / Chronic kidney disease (CKD)

Research History 2

  1. 名古屋大学大学院 医学系研究科   ヘルスケア情報科学実社会情報健康医療学   助教

    2024.4

      More details

  2. International University of Health and Welfare   School of Pharmacy Department of Pharmaceutical Sciences   Assistant Professor   Doctor of Pharmaceutical Sciences

    2023.4 - 2024.3

      More details

    Country:Japan

    researchmap

Education 2

  1. Tokyo University of Pharmacy and Life Science

    2019.4 - 2023.3

  2. Tokyo University of Pharmacy and Life Science

    2013.4 - 2019.3

      More details

    Country: Japan

Professional Memberships 1

  1. Japanese Society of Gout and Uric & Nucleic Acid

    2023.4

      More details

Awards 1

  1. -

    2024.2   Japanese Society of Gout and Uric & Nucleic Acids  

     More details

 

Papers 16

  1. Proteomic footprint of serum urate concentration and urate transporter ABCG2 dysfunctional polymorphism: a cross-sectional study. Reviewed International journal Open Access

    Yuki Ohashi, Sahoko Ichihara, Ken Yamamoto, Yuki Kitamura, Tatsuaki Matsubara, Ruriha Beppo, Fumie Kinoshita, Tomoko S Kato, Yu Toyoda, Yusuke Kawamura, Hirotaka Matsuo, Kimiyoshi Ichida, Mitsuhiro Yokota, Masahiro Nakatochi

    RMD open   Vol. 12 ( 1 )   2026.1

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Existing proteomic studies have primarily focused on gout flares or symptomatic hyperuricaemia, and few have comprehensively investigated circulating proteomic profiles in serum urate (SU) concentration as a continuous quantitative trait. This cross-sectional study investigated the association between SU concentration and serum proteomic profiles. METHODS: We enrolled 176 Japanese individuals aged ≥50 years and measured serum proteins using the Olink Explore 3072. To analyse the association between SU concentration and serum proteins, we applied linear regression adjusting for age, sex, renal function and insulin resistance with a false discovery rate threshold of 5%. Tissue-specific and gene set enrichment analyses were conducted based on the regression results. RESULTS: A total of 2886 proteins were analysed, among whom 63 showed significant associations with SU concentration; uromodulin demonstrated the strongest association (adjusted p=2.21×10-5). These 63 SU-associated proteins were significantly enriched in the liver, kidneys and duodenum by tissue-specific enrichment analysis. We further examined p.Q141K-a dysfunctional variant of adenosine triphosphate-binding cassette subfamily G member 2 (ABCG2). Among p.Q141K minor allele carriers (n=91), 11 SU-associated proteins were identified, whereas no significant SU-associated proteins were detected in wild-type homozygotes (n=85). Gene set enrichment analysis highlighted xenobiotic metabolism in wild-types and additional inflammation- and disease-related gene sets in minor allele carriers. CONCLUSIONS: To the best of our knowledge, this is the first study to report a proteomic signature of SU concentration. These findings suggest that SU-associated proteomic signatures vary according to ABCG2 genotypes, highlighting the genetic contribution to pathophysiological processes associated with SU concentration variation. TRIAL REGISTRATION NUMBER: NCT00262691.

    DOI: 10.1136/rmdopen-2025-006414

    Open Access

    Web of Science

    Scopus

    PubMed

    researchmap

  2. Sex based profiles in serum and urine levels of major VEGF-A isoforms, VEGF-A<sub>121</sub> and VEGF-A<sub>165</sub> (vol. 578, 120576, 2026)

    Kikuchi, R; Yamada, S; Ishida, H; Nakatochi, M; Kobayashi, Y; Ohashi, Y; Kotani, K; Suzuki, A; Shirakami, Y; Watanabe, T; Okura, H

    CLINICA CHIMICA ACTA   Vol. 579   page: 120652   2026.1

     More details

    Language:English   Publisher:Clinica Chimica Acta  

    The authors regret that the name of co-author Kazuhiko Kotani was incorrectly published as Kazuhiro Kotani. The authors would like to apologise for any inconvenience caused.

    DOI: 10.1016/j.cca.2025.120652

    Web of Science

    Scopus

    PubMed

  3. Longitudinal trajectories of health-related quality of life and their predictors among community-dwelling older adults. Reviewed International journal Open Access

    Ryoga Oshima, Yuki Ohashi, Takuro Iwane, Yoshinori Tamada, Fumie Kinoshita, Tomoya Ito, Yuto Okumura, Tatsuya Mikami, Ken Itoh, Koichi Murashita, Masahiro Nakatochi

    Scientific reports   Vol. 16 ( 1 ) page: 872 - 872   2025.12

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    The 36-item Short-Form Health Survey (SF-36) is widely used to assess health-related quality of life. However, only few studies have examined longitudinal SF-36 trajectories in general populations, and even fewer have explored their relationships with lifestyle factors, including sleep quality. We conducted a longitudinal analysis of SF-36 subscale trajectories among 910 Japanese individuals aged ≥ 60 years from 2007 to 2018 (4,799 records). Using latent class mixed models, we identified distinct trajectory patterns for each subscale. Notably, the role-physical (RP) and role-emotional (RE) subscales exhibited multiple patterns, including rapid decline and non-decline trajectories. We further examined predictors that differentiated between these two trajectory patterns-rapid decline and non-decline-with similar baseline scores. Consequently, poor performance on the open-eye one-leg standing test and higher depression scores on the Centre for Epidemiologic Studies Depression Scale predicted RP and RE declines, respectively. Importantly, poor sleep quality, as measured by the Pittsburgh Sleep Quality Index-particularly the total score and component 7 (daytime dysfunction)-was associated with subsequent RP and RE declines. In contrast, sleep timing variables (bedtime, sleep onset, and wake-up time) were not predictive. These findings suggest that preserving good sleep quality may help prevent future limitations in daily physical and emotional roles.

    DOI: 10.1038/s41598-025-30307-8

    Open Access

    Web of Science

    Scopus

    PubMed

    researchmap

  4. Chronic kidney disease progression, long-term nursing care burden and habitual physical activity: an observational study in Japan. Reviewed International journal

    Yuki Ohashi, Akitaka Sugishita, Haruka Kurokawa, Yoko Hori, Sawako Kato, Masaaki Mizuno, Masahiro Nakatochi

    BMJ public health   Vol. 3 ( 2 ) page: e003138   2025.11

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: More than 800 million patients currently have chronic kidney disease (CKD), placing a tremendous burden on both the healthcare and welfare economies. Habitual physical activity in patients with CKD may extend healthy life expectancy without functional disabilities; however, the relationship remains unclear. This study aimed to investigate the impact of habitual physical activity on the association between CKD and long-term nursing care certification. METHODS: This observational cohort study enrolled participants aged >64 years without long-term care certification based on functional disabilities. Habitual physical activity data were obtained using questionnaires, and 8428 participants were classified into the Kidney Disease Improving Global Outcomes risk categories at baseline: no CKD (n=5717), moderately increased risk (n=1980), high risk (n=542) and very high risk (n=189) groups. The primary outcome was long-term care certification, and HRs were estimated using the no CKD group with habitual physical activity as reference. RESULTS: Among the participants with habitual physical activity, very high risk CKD significantly increased the risk of functional disabilities requiring long-term care (HR 1.64, 95% CI 1.04 to 2.58). Meanwhile, non-habitual physical activity significantly increased the risk of functional disabilities with CKD progression, with the HRs for the no CKD, moderately increased risk, high risk and very high risk groups being 1.35 (95% CI 1.16 to 1.57), 1.30 (95% CI 1.07 to 1.58), 1.51 (95% CI 1.16 to 1.96) and 2.30 (95% CI 1.62 to 3.26), respectively. CONCLUSIONS: CKD progression is related to the risk of developing functional disabilities requiring long-term care. Habitual physical activity can help extend healthy life expectancy and reduce CKD-related welfare burden.

    DOI: 10.1136/bmjph-2025-003138

    Web of Science

    PubMed

    researchmap

  5. Evaluation of serum samples in long cryopreservation for SomaScan proteomics and sex differences in elderly Japanese adults. Reviewed International journal Open Access

    Ruriha Beppo, Yuki Ohashi, Ken Yamamoto, Fumie Kinoshita, Tomoko S Kato, Masahisa Katsuno, Tatsuaki Matsubara, Mitsuhiro Yokota, Sahoko Ichihara, Masahiro Nakatochi

    Scientific reports   Vol. 15 ( 1 ) page: 29849 - 29849   2025.8

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    Many biobanks store biological samples and use them for various analyses, including proteomics. Therefore, it is necessary to consider the denaturation of target proteins during long-term storage. We analyzed 16-year-old cryopreserved serum samples using the SomaScan platform, a novel proteomic assay, to determine whether adiponectin and resistin concentrations were consistent with those measured in our previous studies using a different platform. The results suggested that long-term cryopreserved serum samples could be used for future studies of at least adiponectin and resistin, which are closely related to the pathophysiology of diabetes, cardiovascular disease, and other metabolic diseases. Therefore, 7,289 SomaScan-assayed circulating proteins were compared between 20 men and 20 women aged ≥ 50 to determine sex differences. In total, 20 serum proteins showed significant sex differences. Of these, proteins that showed a more than two-fold difference in concentration between sexes contained heterodimeric forms of gonadotropic proteins such as CGA|FSHB, CGA|CGB3|CGB7, and CGA|LHB, which are the biologically active forms of these hormones. The present study is the first to report the possibility of using long-term cryopreserved serum samples for the SomaScan assay, and the results show that the SomaScan assay may be useful for analyzing sex differences focusing on gonadotropic hormones.

    DOI: 10.1038/s41598-025-14464-4

    Open Access

    Web of Science

    Scopus

    PubMed

    researchmap

  6. First verification of human small intestinal uric acid secretion and effect of ABCG2 polymorphisms

    Miyazaki, R; Ohashi, Y; Sakurai, T; Iwamoto, T; Ichida, K; Saruta, M

    JOURNAL OF TRANSLATIONAL MEDICINE   Vol. 23 ( 1 )   2025.3

     More details

    Publisher:Journal of Translational Medicine  

    DOI: 10.1186/s12967-025-06145-7

    Web of Science

    Scopus

    PubMed

  7. Associations among smoking, sleep quality, and decline in Mini-Mental State Examination scores based on health check-up data in Japan: a case-control study

    Nakatochi, M; Yoshida, K; Fujitani, M; Ohashi, Y; Kinoshita, F; Kobayashi, Y; Sato, H; Takahashi, Y; Murashita, K; Hirakawa, A

    NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 87 ( 1 ) page: 105 - 121   2025.2

     More details

    Publisher:Nagoya Journal of Medical Science  

    The number of individuals with age-related mild cognitive impairment and subsequent dementia has inevitably increased with the rise in population aging. It is important to maintain cognitive function or decelerate declines in cognitive function. However, the evidence on lifestyle-based factors associated with this decline is lacking. Here, we investigated modifiable lifestyle-based factors associated with chronological cognitive decline in cognitively healthy adults aged ≥60 years (Mini-Mental State Examination [MMSE] score ≥27). This case-control study enrolled 363 participants who were divided into two groups based on annual declines in MMSE score: 40 cases with an MMSE score decline of ≥0.5 points/year and 323 controls with maintained MMSE scores. Smoking, lower social functioning scores on the 36-Item Short Form Health Survey version 2, higher Pittsburgh Sleep Quality Index (PSQI) global scores, and sleep disorders were significantly associated with a decline in MMSE scores. Multivariate logistic regression analysis revealed higher age, current smoking status, and either higher PSQI global scores or sleep disorders to be independently associated with MMSE score decline. In conclusion, the present study identified aging, smoking, and sleep quality as factors associated with a greater decline in MMSE scores in cognitively healthy individuals. Our findings highlight the potential importance of lifestyle factors in preventing cognitive decline.

    DOI: 10.18999/nagjms.87.1.105

    Web of Science

    Scopus

  8. Status of Community Pharmacy Functions and Regional Medical Collaboration System Initiatives in Japan

    Katsuta Daiki, Ohashi Yuki, Kamimura Minami, Sunaga Shinnosuke, Asami Yuichi, Kuriya Katsuhiro, Yamada Tetsuya, Masuyama Koichi, Kitagaki Kunihiko

    Biological and Pharmaceutical Bulletin   Vol. 47 ( 12 ) page: 2092 - 2100   2024.12

     More details

    Language:English   Publisher:The Pharmaceutical Society of Japan  

    <p>With the increase in life expectancy in Japan, the proportion of older adults requiring medical assistance continues to increase. Hence, the Japanese government proposed the establishment of a community-based integrated care system, aimed at ensuring housing, medical care, long-term care, prevention, and lifestyle support in a comprehensive manner by 2025. To achieve this paradigm shift, pharmacies must collaborate with their respective medical providers. Therefore, we conducted a questionnaire survey to investigate the characteristics of pharmacies with successful regional medical collaborations. An original questionnaire was sent to 1200 randomly sampled pharmacies in Tokyo, of which 350 (29.2%) responded. These were evaluated based on the implementation of regional medical collaboration. The adequacy of a regional medical collaboration system was positively related to the operational structure (<i>e.g.</i>, staffing and information sharing within the pharmacy) and the number of hospitals (including clinics) issuing prescriptions. In addition, insufficient personnel and a lack of interaction with other medical providers were identified as major obstacles to implementing regional collaboration. Notably, the geographic distance from medical providers and the type of division of labor with medical providers were not associated with the adequacy of engagement in a regional medical collaboration system. The results of this study suggest that it may be possible to move closer to the realization of a community-based integrated care system through communication with other healthcare professionals and appropriate staffing regardless of the pharmacy’s business form.</p>

    DOI: 10.1248/bpb.b24-00316

    Web of Science

    Scopus

    PubMed

    CiNii Research

  9. A case of renal hypouricemia due to T217M mutation in SLC22A12 incidentally associated with IgA nephropathy

    Sakurabu, Y; Uchida, HA; Tahara, T; Asakawa, T; Yamasaki, H; Katayama, K; Okamoto, S; Onishi, Y; Matsuoka-Uchiyama, N; Tanaka, K; Takeuchi, H; Tsuji, K; Umebayashi, R; Ohashi, Y; Ichida, K; Wada, J

    CLINICAL CASE REPORTS   Vol. 12 ( 9 ) page: e9368   2024.9

     More details

  10. Plasma and Urinary Metabolomic Analysis of Gout and Asymptomatic Hyperuricemia and Profiling of Potential Biomarkers: A Pilot Study. Reviewed Open Access

    Yuki Ohashi, Hiroshi Ooyama, Hideki Makinoshima, Tappei Takada, Hirotaka Matsuo, Kimiyoshi Ichida

    Biomedicines   Vol. 12 ( 2 )   2024.1

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3390/biomedicines12020300

    Open Access

  11. Changes in Regional Medical Collaboration System and Functions in Community Pharmacy Before and After the Enforcement of the Amended Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices in Tokyo(タイトル和訳中) Reviewed

    Katsuta Daiki, Ohashi Yuki, Kamimura Minami, Yamada Tetsuya, Masuyama Koichi, Kitagaki Kunihiko

    BPB Reports   Vol. 7 ( 6 ) page: 183 - 189   2024

     More details

    Language:English   Publisher:(公社)日本薬学会  

    researchmap

  12. Urate Transporter ABCG2 Function and Asymptomatic Hyperuricemia: A Retrospective Cohort Study of CKD Progression. Reviewed

    Yuki Ohashi, Satoru Kuriyama, Tomoko Nakano, Mai Sekine, Yu Toyoda, Akiyoshi Nakayama, Tappei Takada, Yusuke Kawamura, Takahiro Nakamura, Hirotaka Matsuo, Takashi Yokoo, Kimiyoshi Ichida

    American journal of kidney diseases   Vol. 81 ( 2 ) page: 134 - 144   2023.2

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1053/j.ajkd.2022.05.010

  13. Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients. Reviewed Open Access

    Yuki Ohashi, Masao Toyoda, Nobumichi Saito, Masahiro Koizumi, Genta Kanai, Hirotaka Komaba, Moritsugu Kimura, Takehiko Wada, Hiroo Takahashi, Yuichiro Takahashi, Naoto Ishida, Takatoshi Kakuta, Masafumi Fukagawa, Kimiyoshi Ichida

    Scientific reports   Vol. 13 ( 1 ) page: 93 - 93   2023.1

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-022-26519-x

    Open Access

  14. Analysis of Purine Metabolism to Elucidate the Pathogenesis of Acute Kidney Injury in Renal Hypouricemia. Reviewed International coauthorship Open Access

    Daisuke Miyamoto, Nana Sato, Koji Nagata, Yukinao Sakai, Hitoshi Sugihara, Yuki Ohashi, Blanka Stiburkova, Ivan Sebesta, Kimiyoshi Ichida, Ken Okamoto

    Biomedicines   Vol. 10 ( 7 )   2022.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3390/biomedicines10071584

    Open Access

  15. Renal hypouricemia in a recipient of living-donor kidney transplantation: a case report and literature review. Reviewed Open Access

    Takamasa Miyauchi, Maho Terashita, Masatomo Ogata, Marie Murata, Kiyomi Osako, Naohiko Imai, Yuko Sakurai, Hideo Sasaki, Yuki Ohashi, Kimiyoshi Ichida, Yugo Shibagaki, Masahiko Yazawa

    CEN case reports   ( 2 ) page: 177 - 183   2022.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s13730-021-00647-1

    Open Access

  16. Dysfunctional ABCG2 gene polymorphisms are associated with serum uric acid levels and all-cause mortality in hemodialysis patients. Reviewed Open Access

    Akio Nakashima, Kimiyoshi Ichida, Ichiro Ohkido, Keitaro Yokoyama, Hirotaka Matsuo, Yuki Ohashi, Tappei Takada, Akiyoshi Nakayama, Hiroshi Suzuki, Nariyoshi Shinomiya, Mitsuyoshi Urashima, Takashi Yokoo

    Human cell   Vol. 33 ( 3 ) page: 559 - 568   2020.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s13577-020-00342-w

    Open Access

▼display all

Presentations 12

  1. Intestinal uric acid secretion and ABCG2 function Invited

    Yuki Ohashi

    The 8th Asia-Pacific Gout Consortium (APGC) meeting  2025.9.26 

     More details

    Event date: 2025.9

    Language:English   Presentation type:Oral presentation (invited, special)  

    researchmap

  2. -

    Yuki OHASHI, Kimiyoshi ICHIDA

    2024.2.29 

     More details

    Event date: 2024.2 - 2024.3

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  3. CKD 患者に及ぼす尿酸トランスポーターABCG2 の保護的役割の解明

    大橋勇紀, 柴田茂, 高田龍平, 松尾洋孝, 内田俊也, 市田公美

    第 53 回日本痛風・尿酸核酸学会総会  2020.2.13 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  4. 遊離アミノ酸プロファイルを用いた血清尿酸値の規定因子の探索

    大橋勇紀, 市田公美

    第57回日本痛風・尿酸核酸学会総会  2024.2.29 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  5. Relation of Urate Transporter ABCG2 Function with Asymptomatic Hyperuricemia and Hypouricemia: A Retrospective Cohort Study of CKD Progression. International conference

    Yuki Ohashi, Satoru Kuriyama, Tomoko Nakano, Kimiyoshi Ichida

    FEBS Special Meeting 2023 ATP-Binding Cassette (ABC) Proteins: From multidrug Resistance to Genetic Disease  2023.3.1 

     More details

    Language:English   Presentation type:Poster presentation  

    Country:Austria  

  6. Identification of Potential Biomarkers for the Progression from Asymptomatic Hyperuricemia to Gout using Plasma and Urinary Metabolomics. International conference

    Yuki Ohashi, Hiroshi Oyama, Hideki Makinoshima, Kimiyoshi Ichida

    24th Asia-Pacific League of Associations for Rheumatology Congress  2022.12 

     More details

    Language:English   Presentation type:Poster presentation  

    Country:Hong Kong  

  7. ABCG2 による腎外尿酸排泄量の推定

    大橋勇紀, 豊田雅夫, 市田公美

    第 65 回日本腎臓学会学術総会  2022.6.11 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  8. 健常人における腎機能と ABCG2 機能低下の関係

    大橋勇紀, 中野知子, 栗山啓, 市田公美

    第 64 回日本腎臓学会学術総会  2021.6.19 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  9. Decreased ABCG2 Activity Accelerates the Age-Dependent Decline in Renal Function. International conference

    Yuki Ohashi, Satoru Kuriyama, Kimiyoshi Ichida

    The 19th International Purine and Pyrimidine Symposium (online)  2021.6.15 

     More details

    Language:English   Presentation type:Oral presentation (general)  

  10. Renoprotective Effects of Urate Transporter ABCG2 in CKD patients International conference

    Yuki Ohashi, Shunya Uchida, Tappei Takada, Hirotaka Matsuo, Shigeru Shibata, Kimiyoshi Ichida

    FEBS Special Meeting 2020 ATP-Binding Cassette (ABC) Proteins: From multidrug Resistance to Genetic Disease  2020.3.5 

     More details

    Language:English   Presentation type:Poster presentation  

    Country:Austria  

  11. 尿路結石症と尿酸トランスポーターABCG2の関連性の解明

    第58回日本痛風・尿酸核酸学会総会  2025.2 

     More details

    Presentation type:Poster presentation  

    researchmap

  12. 尿酸トランスポーターABCG2が尿中尿酸排泄に与える影響とその性差の検討

    日本薬学会第145年会  2025.3 

     More details

    Presentation type:Poster presentation  

    researchmap

▼display all

Other research activities 2

  1. 月刊薬事 増刊「10 年間で登場した薬剤の市販後を総点検! 病棟頻用薬の通信簿」

    2024.4

     More details

  2. 月刊薬事9月号特集企画「透析患者のくすりの疑問」

    2023.9

     More details

    透析患者の尿酸値上昇と腸管ABCG2の機能低下の関連性

    researchmap

Research Project for Joint Research, Competitive Funding, etc. 2

  1. 分子遺伝疫学解析による尿酸トランスポーター機能と腎機能との関連性の解明

    2023.4 - 2025.3

    日本痛風・尿酸核酸学会 若手研究助成 

      More details

    Authorship:Principal investigator 

    Grant amount:\200000

  2. .

    2023.4 - 2025.3

      More details

KAKENHI (Grants-in-Aid for Scientific Research) 3

  1. 透析患者における痛風予防・血清尿酸値管理の個別最適化に向けたモデル開発

    Grant number:25K20543  2025.4 - 2028.3

    科学研究費助成事業  若手研究

    大橋 勇紀

      More details

    Authorship:Principal investigator 

    Grant amount:\4810000 ( Direct Cost: \3700000 、 Indirect Cost:\1110000 )

    透析患者の多くは高齢者であり、腎機能が廃絶している性質上、多くの合併症により多剤併用となっているケースがほとんどである。従って人工透析下では、ポリファーマシーが治療上の大きな課題となっている。本研究は、透析患者の遺伝的背景を含む個人特性を考慮して、データサイエンスの領域から「真に服薬が必要な透析患者」の判別を可能とするアルゴリズムを創成する。

  2. An international (Japan-USA-Vietnam) collaborative research for molecular genetic epidemiology in urate-related diseases including gout and hyperuricemia

    Grant number:24KK0177  2024.9 - 2027.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Fund for the Promotion of Joint International Research (International Collaborative Research)

      More details

    Authorship:Coinvestigator(s) 

    researchmap

  3. 尿酸トランスポーターの一塩基多型に着目した尿路結石症発症のリスク評価

    Grant number:23K19387  2023.8 - 2025.3

    日本学術振興会  科学研究費助成事業  研究活動スタート支援

    大橋 勇紀

      More details

    Authorship:Principal investigator  Grant type:Competitive

    Grant amount:\2860000 ( Direct Cost: \2200000 、 Indirect Cost:\660000 )

    尿路結石症の生涯罹患率は男性で約15%、女性で約7%と非常に高く、その激しい疝痛と排尿困難から患者のQOLを著しく損なう。このような罹患率の高さ、また腎保護的な観点から、尿路結石症に対する予防やハイリスク群同定の医学的根拠の重要性は高い。しかしながら、シスチン尿症やキサンチン尿症のような一部の単一遺伝疾患以外の尿路結石症の遺伝的関与はほとんど明らかになっていない。本研究では尿酸動態に強く影響する尿酸トランスポーターであるABCG2に着目し、既知の健常集団とのABCG2遺伝子変異頻度の差異を調査する。さらには、ABCG2遺伝子多型による尿酸動態の変化と尿路結石症発症との関連性についても検討する。

    researchmap

 

Teaching Experience (Off-campus) 2

  1. Medical Statistics

    2025.4 Nagoya University)

     More details

  2. Practical training(OSCE)

    2023.4 International University of Health and Welfare)

     More details

 

Media Coverage 2

  1. ヒト消化管からの尿酸分泌を世界で初めて測定 -痛風・高尿酸血症治療の重要なターゲットとして小腸 ABCG2 に注目- Internet

    時事メディカル  https://medical.jiji.com/topics/3791  2025.2

     More details

  2. ヒト消化管からの尿酸分泌を世界で初めて測定 -痛風・高尿酸血症治療の重要なターゲットとして小腸ABCG2に注目- Internet

    時事通信社  時事メディカル  https://medical.jiji.com/topics/3791 

     More details